Jiejun Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiejun Wu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Honglin Yu
University of Science and Technology of China, China
1 shared publication - Hu Mao
Department of Urology
1 shared publication - Jun Jian
Renmin Hospital of Wuhan University, China
1 shared publication - Lei Wang
Department of Urology Renmin Hospital of Wuhan University Wuhan Hubei China
1 shared publication - Ruikang Feng
Renmin Hospital of Wuhan University, China; Renmin Hospital of Wuhan University, China
1 shared publication - Xiuheng Liu
Department of Urology Renmin Hospital of Wuhan University Wuhan Hubei China
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 38 (1) , e381023
Cyanidin-3-O-glucoside plays a protective role against renal ischemia/ reperfusion injury via the JAK/STAT pathway
To investigate the role of cyanidin-3-O-glucoside (C3G) in renal ischemia/reperfusion (I/R) injury and the potential mechanisms. Mouse models were established by clamping the left renal vessels, and in vitro cellular models were established by hypoxic reoxygenation. Renal dysfunction and tissue structural damage were significantly higher in the I/R group. After treatment with different concentrations of C3G, the levels of renal dysfunction and tissue structural damage decreased at different levels. And its protective effect was most pronounced at 200 mg/kg. The use of C3G reduced apoptosis as well as the expression of endoplasmic reticulum stress (ERS)-related proteins. Hypoxia/reoxygenation (H/R)-induced apoptosis and ERS are dependent on oxidative stress in vitro. In addition, both AG490 and C3G inhibited the activation of JAK/STAT pathway and attenuated oxidative stress, ischemia-induced apoptosis and ERS. The results demonstrated that C3G blocked renal apoptosis and ERS protein expression by preventing reactive oxygen species (ROS) production after I/R via the JAK/STAT pathway, suggesting that C3G may be a potential therapeutic agent for renal I/R injury.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 38 (1) , e381023
Open AccessCyanidin-3-O-glucoside plays a protective role against renal ischemia/ reperfusion injury via the JAK/STAT pathway
To investigate the role of cyanidin-3-O-glucoside (C3G) in renal ischemia/reperfusion (I/R) injury and the potential mechanisms. Mouse models were established by clamping the left renal vessels, and in vitro cellular models were established by hypoxic reoxygenation. Renal dysfunction and tissue structural damage were significantly higher in the I/R group. After treatment with different concentrations of C3G, the levels of renal dysfunction and tissue structural damage decreased at different levels. And its protective effect was most pronounced at 200 mg/kg. The use of C3G reduced apoptosis as well as the expression of endoplasmic reticulum stress (ERS)-related proteins. Hypoxia/reoxygenation (H/R)-induced apoptosis and ERS are dependent on oxidative stress in vitro. In addition, both AG490 and C3G inhibited the activation of JAK/STAT pathway and attenuated oxidative stress, ischemia-induced apoptosis and ERS. The results demonstrated that C3G blocked renal apoptosis and ERS protein expression by preventing reactive oxygen species (ROS) production after I/R via the JAK/STAT pathway, suggesting that C3G may be a potential therapeutic agent for renal I/R injury.